BenchSci, a disease biology generative AI platform, announced a three-year agreement with biopharmaceutical company Sanofi to deploy and use its Ascend platform throughout Sanofi's preclinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results